Vaccine Therapy in Treating Patients With Kidney Cancer

Summary

RATIONALE: Vaccines made from a patient's white blood cells and tumor cells may make the body build an immune response to kill tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of vaccine therapy in treating patients who have recurrent or stage III or stage IV kidney cancer.

Timeline

Start

2001-11

Primary completion

2009-12

Completion

2009-12

Drugs

Indications